References

The National Comprehensive Cancer Network Guidelines

The Children's Oncology Group Long Term Follow Up Guidelines

(2006). "Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients. " J Support Oncol 4(2): 66-7.

(2004)."A National Action Plan for Cancer Survivorship: Advancing Public Health Strategies" Centers for Disease Control and Prevention and the Lance Armstrong Foundation (accessed online).

(2004). "Cancer survivorship--United States, 1971-2001. " MMWR Morb Mortal Wkly Rep 53 (24): 526-9.

(2007). "Coming together to improve care. " Am J Nurs 107 (4): 66.

Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease.J Clin Oncol.2003;21:3431-9.

Ahles, T.A.and A.J. Saykin (2007). "Cand idate mechanisms for chemotherapy-induced cognitive changes. " Nat Rev Cancer 7(3): 192-201.

Alfano, C. M. and J. H. Rowland (2006). "Recovery issues in cancer survivorship: a new challenge for supportive care." Cancer J 12(5): 432-43.

Baker, F., M. Denniston, et al. (2005). "Adult cancer survivors: how are they faring?" Cancer 104 (11 Suppl): 2565-76.

Baum, M., A. Buzdar, et al. (2003). "Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses." Cancer 98 (9): 1802-10.

Bhatia S, Yasui Y, Robison LL, High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.J Clin Oncol.2003;21:4386-94.

Bokemeyer, C., C.C. Berger, et al. (1996). "Evaluation of long-term toxicity after chemotherapy for testicular cancer." J Clin Oncol 14 (11): 2923-32.

Bower, J.E.(2005). "Prevalence and Causes of Fatigue After Cancer Treatment: The Next Generation of Research." J Clin Oncol 23 (33): 8280-8282.

Braun, I. M., D. B. Greenberg, et al. (2008). "Evidenced-based report on the occurrence of fatigue in long-term cancer survivors." J Natl Compr Canc Netw 6(4): 347-54.

Buzdar, A.U.(2004). "Data from the Arimidex, tamoxifen, alone or in combination ( ATAC ) trial: implications for use of aromatase inhibitors in 2003. " Clin Cancer Res 10 (1 Pt 2): 355S-61S.

Camp-Sorrell, D.(2006). "Cardiorespiratory effects in cancer survivors.Cardiac and pulmonary toxicities may occur as late or long-term sequelae of cancer treatment. " Am J Nurs 106 (3 Suppl): 55-9.

Cannon, G.W.(1997). "Methotrexate pulmonary toxicity. " Rheum Dis Clin North Am 23 (4): 917-37.

Cardous-Ubbink, M.C., R.C.Heinen, et al. (2004). "Long-term cause-specific mortality among five-year survivors of childhood cancer. " Pediatr Blood Cancer 42 (7): 563-73.

Carver, J.R., C.L. Shapiro, et al. (2007). "American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects." J Clin Oncol.

Chaudhary UB, Haldas JR.Long-term complications of chemotherapy for germ cell tumours.Drugs.2003;63:1565-77.

Demark-Wahnefried, W., B.M. Pinto, et al. (2006). "Promoting health and physical function among cancer survivors: potential for prevention and questions that remain." J Clin Oncol 24 (32): 5125-31.

Deniz K, O'Mahony S, Ross G, et al. Breast cancer in women after treatment for Hodgkin's disease.Lancet Oncol.2003;4:207-14.

Doyle, J.J., A.I. Neugut, et al. (2005). "Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study." J Clin Oncol 23 (34): 8597-605.

Earle, C.C.(2006). "Failing to plan is planning to fail: improving the quality of care with survivorship care plans." J Clin Oncol 24 (32): 5112-6.

Elisaf, M.S., E.T. Bairaktari, et al. (2001). "Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. " Eur J Cancer 37 (12): 1510-3.

Feuerstein, M.(2005). "Cancer survivorship and work. " J Occup Rehabil 15 (1): 1-2.

Fossa, S.D.(2004). "Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer. " Acta Oncol 43 (2): 134-41.

Friedman, D.L., A. Rovo, et al. (2008). "Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party." Blood 111(2): 939-44.

Friedman, D.L. and L.S. Constine (2006). "Late effects of treatment for Hodgkin lymphoma. " J Natl Compr Canc Netw 4 (3): 249-57.

Jansen, C.E., C. Miaskowski, et al. (2005). "A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. " Cancer 104(10): 2222-33.

Ganz, P.A.(2006). "Monitoring the physical health of cancer survivors: a survivorship-focused medical history." J Clin Oncol 24 (32): 5105-11.

Ganz, P.A., C.M. Moinpour, et al. (2003). "Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133." J Clin Oncol 21 (18): 3512-9.

Ganz, P.A. and E.E. Hahn (2008). "Implementing a survivorship care plan for patients with breast cancer." J Clin Oncol 26(5): 759-67.

Ganz, P.A., M.A. Hussey, et al. (2008). "Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897." J Clin Oncol 26(8): 1223-30.

Greving, D.M.and S.J. Santacroce (2005). "Cardiovascular late effects. " J Pediatr Oncol Nurs 22 (1): 38-47.

Grunfeld, E.(2005). "Cancer survivorship: a challenge for primary care physicians. " Br J Gen Pract 55 (519): 741-2.

Grunfeld, E.(2006). "Looking beyond survival: how are we looking at survivorship?" J Clin Oncol 24 (32): 5166-9.

Guidry, J.J., W. Torrence, et al. (2005). "Closing the divide: diverse populations and cancer survivorship. " Cancer 104 (11 Suppl): 2577-83.

Haddy, T.B., M.A. Adde, et al. (1998). "Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas." J Clin Oncol 16 (6): 2070-9.

Hanson, K. (2006). "State cancer survivorship policies." NCSL Legisbrief 14(47): 1-2.

Hawkins, R.(2006). "Osteoporosis.Cancer survivors are at increased risk for osteoporosis, but how their management differs from that of the general population remains unclear. " Am J Nurs 106 (3 Suppl): 78-82.

Haylock, P.J., S.A. Mitchell, et al. (2007). "The Cancer Survivor's Prescription for Living. " Am J Nurs 107 (4): 58-70.

Heidenreich, PA et al. Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease.Journal of Clinical Oncology 2007;25:43-49.

Henderson, T.O., J. Whitton, et al. (2007). "Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study." J Natl Cancer Inst 99(4): 300-8.

Hequet, O., Q.H. Le, et al. (2004). "Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults." J Clin Oncol 22 (10): 1864-1871.

Herman, D.R., P.A. Ganz, et al. (2005). "Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). " Breast Cancer Res Treat 93 (1): 13-23.

Hoffman, B.and E. Stovall (2006). "Survivorship perspectives and advocacy." J Clin Oncol 24 (32): 5154-9.

Houldin, A., C.P. Curtiss, et al. (2006). "Executive summary: The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. " Am J Nurs 106 (3): 54-9.

Houldin, A., C.P. Curtiss, et al. (2006). "The state of the science on nursing approaches to managing late and long-term sequelae of cancer and cancer treatment. " Clin J Oncol Nurs 10 (3): 327-32.

Hudson, M.M.(2005). "A model for care across the cancer continuum. " Cancer 104 (11 Suppl): 2638-42.

Institute of Medicine and the National Research Council (2005) "From Cancer Patient to Cancer Survivor: Lost in Transition" The National Academies Press, Washington, DC.

Jensen, B.V.(2006). "Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. " Semin Oncol 33 (3 Suppl 8): S15-21.

Johnson, S.A.(2006). "Anthracycline-induced cardiotoxicity in adult hematologic malignancies. " Semin Oncol 33 (3 Suppl 8): S22-7.

Jones, K.W.and S.R. Patel (2000). "A family physician's guide to monitoring methotrexate. " Am Fam Physician 62 (7): 1607-12, 1614.

Josting A, Wiedenmann S, Franklin J, Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.J Clin Oncol.2003;21:3440-6.

Kaufman, M.R. and S.S. Chang (2007). "Short- and long-term complications of therapy for testicular cancer." Urol Clin North Am 34(2): 259-68; abstract xi.

Keefe, D.L.(2001). "Anthracycline-induced cardiomyopathy. " Semin Oncol 28 (4 Suppl 12): 2-7.

Lee, S.J., L.R. Schover, et al. (2006). "American Society of Clinical Oncology recommendations on fertility preservation in cancer patients." J Clin Oncol 24 (18): 2917-31.

Leigh, S.(2006). "Cancer survivorship: A first-person perspective.A nurse recounts her journey as patient, survivor, and advocate. " Am J Nurs 106 (3 Suppl): 12-4.

Leitao, M.M., Jr.and D.S. Chi (2005). "Fertility-sparing options for patients with gynecologic malignancies. " Oncologist 10 (8): 613-22.

Lockwood-Rayermann, S.(2006). "Survivorship issues in ovarian cancer: a review. " Oncol Nurs Forum 33 (3): 553-62.

McCaffrey, J.A.and H.I. Scher (1998). "Interstitial pneumonitis following bicalutamide treatment for prostate cancer. " J Urol 160 (1): 131.

Meadows, AT (2001) "Pediatric Cancer Survivors: Past History and Future Challenges." P repared in 2001 for the National Cancer Policy Board, Institute of Medicine (accessed online).

Meadows, A.T.(2006). "Pediatric Cancer Survivorship: Research and Clinical Care." J Clin Oncol 24 (32): 5160-5165.

Meinardi, M.T., J.A. Gietema, et al. (2000). "Cardiovascular morbidity in long-term survivors of metastatic testicular cancer." J Clin Oncol 18 (8): 1725-32.

Meinardi, M.T., J.A. Gietema, et al. (2000). "Long-term chemotherapy-related cardiovascular morbidity. " Cancer Treat Rev 26 (6): 429-47.

Michaud, L.B.and S. Goodin (2006). "Cancer-treatment-induced bone loss, part 1. " Am J Health Syst Pharm 63 (5): 419-30.

Michaud, L.B.and S. Goodin (2006). "Cancer-treatment-induced bone loss, part 2. " Am J Health Syst Pharm 63 (6): 534-46.

Moleski, M.(2000). "Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. " Arch Clin Neuropsychol 15(7): 603-30.

Mrozek, E. and C.L. Shapiro (2005). "Survivorship and complications of treatment in breast cancer." Clin Adv Hematol Onco l3(3): 211-22, 238.

Nayfield, S.G.and M.B. Gorin (1996). "Tamoxifen-associated eye disease.A review." J Clin Oncol 14 (3): 1018-26.

Nelson, M.B.and K. Meeske (2005). "Recognizing health risks in childhood cancer survivors. " J Am Acad Nurse Pract 17 (3): 96-103.

Nieman, C.L., R .Kazer, et al. (2006). "Cancer survivors and infertility: a review of a new problem and novel answers. " J Support Oncol 4 (4): 171-8.

Oeffinger, K.C., A.C. Mertens, et al. (2006). "Chronic health conditions in adult survivors of childhood cancer. " N Engl J Med 355 (15): 1572-82.

Oeffinger, K.C. and M. S. McCabe (2006). "Models for delivering survivorship care." J Clin Oncol 24(32): 5117-24.

Oktay, K.(2006). "An individualized approach to fertility preservation in women with cancer. " J Support Oncol 4 (4): 181-2, 184.

Polomano, R.C.and J.T. Farrar (2006). "Pain and neuropathy in cancer survivors.Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. " Am J Nurs 106 (3 Suppl): 39-47.

Rheingold, SR, Neugut, AI and AT Meadows (2003)."Secondary Cancers: Incidence, Risk Factors and Management" In Editors: Kufe, DW et.al.Cancer Medicine, 6 th ed., BC Decker, Ontario.

Riva, D., C. Giorgi, et al. (2002). "Intrathecal methotrexate affects cognitive function in children with medulloblastoma. " Neurology 59(1): 48-53.

Robison, L.L., D.M. Green, et al. (2005). "Long-term outcomes of adult survivors of childhood cancer. " Cancer 104 (11 Suppl): 2557-64.

Schagen, S.B., M.J. Muller, et al. (2006). "Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. " J Natl Cancer Inst 98(23): 1742-5.

Schagen, S.B.and F.S. van Dam (2006). "Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?" J Clin Oncol 24(32): 5170-1; author reply 5171-2.

Simon, B., S.J. Lee, et al. (2005). "Preserving fertility after cancer. " CA Cancer J Clin 55 (4): 211-28; quiz 263-4.

Sleijfer, S.(2001). "Bleomycin-induced pneumonitis. " Chest 120 (2): 617-24.

Stapleton, S.and S. Blaney (2006). "New agents for intrathecal administration. " Cancer Invest 24(5): 528-34.

Steinherz, L.J., P.G. Steinherz, et al. (1991). "Cardiac toxicity 4 to 20 years after completing anthracycline therapy. " Jama 266 (12): 1672-7.

Sugimura, H.and P. Yang (2006). "Long-term survivorship in lung cancer: a review. " Chest 129 (4): 1088-97.

Thomson, A.B., H.O. Critchley, et al. (2002). "Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. " Best Pract Res Clin Endocrinol Metab 16 (2): 311-34.

Vardy, J., S. Rourke, et al. (2007). "Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research." J Clin Oncol 25(17): 2455-63.

Vaughn, D.J.and A.T. Meadows (2002). "Cancer survivorship research: the best is yet to come." J Clin Oncol 20 (4): 888-90.

Wallace, W.H.and R.A. and erson (2006). "Cancer survivors and infertility: where do we go from here?" J Support Oncol 4 (4): 183-4.

Wong, P.W., N. Macris, et al. (1998). "Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature. " Chest 113 (2): 548-50.

Woodward WA, Strom EA, McNeese MD, Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.Int J Radiat Oncol Biol Phys.2003;57:327-35.

Yabroff, K.R., W.F. Lawrence, et al. (2004). "Burden of illness in cancer survivors: findings from a population-based national sample. " J Natl Cancer Inst 96 (17): 1322-30.

Zoltick, B.H., L.A. Jacobs, et al. (2005). "Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications. " Oncol Nurs Forum 32 (5): 1005-9; quiz 1010-1.